Healthcare Bizdev
HCBD-Pro Services Client Subscribers

HCBD-PRO Services

Query News -

Welcome <Guest> Login
back to News
 
Independence Blue Cross to place additional restrictions on OxyContin and Oxycodone ER to help reduce opioid use and abuse

Source Independence Blue Cross (IBC)
Published Date 8/7/2018
Independence Blue Cross (Independence) announced that as part of its commitment to helping reduce opioid misuse and overprescribing, it is placing new restrictions on OxyContin® and Oxycodone ER. These products will be removed from some formularies and will require a new prior authorization on others, effective October 1. ...
View the entire Independence Blue Cross (IBC) article
    LinkedIn
 
Featured Companies
Independence Blue Cross (IBC)
Philadelphia, PA
 

Company Representatives Featured
Richard L. Snyder MD
[Chief Medical Officer]
Independence Blue Cross (IBC)
 
Ruth Stoolman
[Corporate and Public Affairs]
Independence Blue Cross (IBC)
Media Contact
 
 
back to News
About Us | Purchase Pro | Contact Us

© 2006-2010 Healthcare BizDev, Inc. All rights reserved. Privacy Policy | Legal Conditions